Tetraphase Pharmaceuticals Inc (TTPH) - Financial and Strategic SWOT Analysis Review

Date: February 14, 2018
Pages: 37
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: TF26C67256DEN
Leaflet:

Download PDF Leaflet

Tetraphase Pharmaceuticals Inc (TTPH) - Financial and Strategic SWOT Analysis Review
Tetraphase Pharmaceuticals Inc (TTPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Tetraphase Pharmaceuticals Inc (Tetraphase) is a pharmaceutical company that discovers and develops antibiotic resistance medicines. The company’s products under clinical development include eravacycline, TP-271, and TP-6076. It develops products for the treatment of respiratory diseases caused by bacterial biothreat and antibiotic resistant public health pathogens. Tetraphase’s eravacycline is used for the treatment of multi-drug resistant (MDR) infections which include MDR gram-negative bacteria. The company offers drugs in therapeutic areas of antibiotics, oncology and inflammatory diseases. It also offers research and creation of tetracycline drugs. Tetraphase is headquartered in Watertown, Massachusetts, the US.

Tetraphase Pharmaceuticals Inc Key Recent Developments

Nov 02,2017: Tetraphase Pharmaceuticals Reports Third Quarter 2017 Financial Results and Highlights Recent Clinical and Corporate Achievements
Oct 16,2017: Tetraphase Pharmaceuticals Appoints Kam Unninayar as Chief Financial Officer
Aug 02,2017: Tetraphase Pharmaceuticals Reports Second Quarter 2017 Financial Results
Aug 02,2017: Tetraphase Q2 net loss up
May 04,2017: Tetraphase Pharmaceuticals Reports First Quarter 2017 Financial Results and Reviews Recent Highlights

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

NOTE: Out of security concerns GlobalData requires using corporate email address.
SECTION 1 - ABOUT THE COMPANY

Tetraphase Pharmaceuticals Inc - Key Facts
Tetraphase Pharmaceuticals Inc - Key Employees
Tetraphase Pharmaceuticals Inc - Major Products and Services
Tetraphase Pharmaceuticals Inc - History
Tetraphase Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Tetraphase Pharmaceuticals Inc - Business Description
R&D Overview
Tetraphase Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Tetraphase Pharmaceuticals Inc - Strengths
Tetraphase Pharmaceuticals Inc - Weaknesses
Tetraphase Pharmaceuticals Inc - Opportunities
Tetraphase Pharmaceuticals Inc - Threats
Tetraphase Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Tetraphase Pharmaceuticals Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Nov 02, 2017: Tetraphase Pharmaceuticals Reports Third Quarter 2017 Financial Results and Highlights Recent Clinical and Corporate Achievements
Oct 16, 2017: Tetraphase Pharmaceuticals Appoints Kam Unninayar as Chief Financial Officer
Aug 02, 2017: Tetraphase Pharmaceuticals Reports Second Quarter 2017 Financial Results
Aug 02, 2017: Tetraphase Q2 net loss up
May 04, 2017: Tetraphase Pharmaceuticals Reports First Quarter 2017 Financial Results and Reviews Recent Highlights
Mar 08, 2017: Tetraphase Pharmaceuticals Reports Fourth Quarter and Full-Year 2016 Financial Results and Highlights Key 2017 Milestones

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Tetraphase Pharmaceuticals Inc, Key Facts
Tetraphase Pharmaceuticals Inc, Key Employees
Tetraphase Pharmaceuticals Inc, Major Products and Services
Tetraphase Pharmaceuticals Inc, History
Tetraphase Pharmaceuticals Inc, Subsidiaries
Tetraphase Pharmaceuticals Inc, Key Competitors
Tetraphase Pharmaceuticals Inc, Ratios based on current share price
Tetraphase Pharmaceuticals Inc, Annual Ratios
Tetraphase Pharmaceuticals Inc, Annual Ratios (Cont.1)
Tetraphase Pharmaceuticals Inc, Interim Ratios
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Tetraphase Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Tetraphase Pharmaceuticals Inc, Performance Chart (2012 - 2016)
Tetraphase Pharmaceuticals Inc, Ratio Charts
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

COMPANIES MENTIONED

Humanigen Inc
CorMedix Inc
Cempra Inc
Achaogen Inc
Skip to top


Ask Your Question

Tetraphase Pharmaceuticals Inc (TTPH) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: